Discrepancies between anti-Intereukin5 ( anti-IL5) starters from SHARP central registry and eligible patients in clinical trials

被引：0
|
作者：
Principe, S. [1 ]
Richards, L. B. [1 ,2 ]
Hashimoto, S. [1 ,2 ]
Kroes, J. A. [3 ]
Van Bragt, J. J. [1 ,2 ]
Vijverberg, S. J. [1 ,2 ]
Sont, J. K. [4 ]
Scichilone, N. [2 ]
Bieksiene, K. [5 ]
Brinke, A. T. [6 ]
Csoma, Z. [7 ]
Dahlen, B. [8 ]
Gemicioglu, B. [9 ]
Grisle, I [10 ]
Kuna, P. [11 ]
Lazic, Z. [12 ]
Mihaltan, F. [13 ]
Popovic-Grle, S. [14 ]
Skgrat, S. [15 ]
Van der Zee, A. Maitland [1 ,2 ]
机构：
[1] Univ Amsterdam, Dept Resp Med, Med Ctr, Amsterdam, Netherlands
[2] Univ Palermo, Dept Pulmonol, AOUP Policlin Paolo Giaccone, Palermo, Italy
[3] Med Ctr Leeuwarden, Dept Clin Pharm & Pharmacol, Leeuwarden, Netherlands
[4] Leiden Univ, Dept Biomed Data Sci, Sect Med Decis Making, Med Ctr, Leiden, Netherlands
[5] Lithuanian Univ Hlth Sci, Dept Pulmonol, Kaunas, Lithuania
[6] Med Ctr Leeuwarden, Leeuwarden, Netherlands
[7] Natl Koranyi Inst Pulmonol, Budapest, Hungary
[8] Karolinska Inst, Stockholm, Sweden
[9] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Pulm Dis, Istanbul, Turkey
[10] Riga East Univ Hosp, Riga, Latvia
[11] Med Univ Lodz, Lodz, Poland
[12] Univ Clin Ctr Kragujevac, Kragujevac, Serbia
[13] Natl Inst Pneumol, Bucharest, Romania
[14] Univ Hosp Ctr Zagreb, KBCZ Clin Ctr Pulm Dis Jordanovac, Zagreb, Croatia
[15] Univ Ljubljana, Univ Med Ctr Ljubljana, Med Fac, Pulm Dept, Ljubljana, Slovenia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.2197
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2197
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Heterogeneous ILC responses in severe asthma patients undergoing anti-IL5/5Rα therapy
    Mincham, Kyle
    Loewenthal, Lola
    Meyer, Garance
    Marfia, Martina
    Martin, Minerva Garcia
    Patel, Pujan
    Lloyd, Clare
    Snelgrove, Robert
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 19 - 19
  • [22] Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe Asthma
    Soendergaard, Marianne Baastrup
    Hansen, Susanne
    Hakansson, Kjell Erik Julius
    von Bulow, Anna
    Bjerrum, Anne-Sofie
    Schmid, Johannes Martin
    Johansson, Sofie Lock
    Rasmussen, Linda Makowska
    Johnsen, Claus Rikard
    Bertelsen, Barbara Bonnesen
    Krogh, Niels Steen
    Hilberg, Ole
    Ulrik, Charlotte Suppli
    Porsbjerg, Celeste
    ALLERGY, 2024,
  • [23] Heterogeneous ILC responses in severe asthma patients undergoing anti-IL5/5Ra therapy
    Mincham, Kyle
    Loewentha, Lola
    Meyer, Garance
    Marfia, Martina
    Martin, Minerva Garcia
    Patel, Pujan
    Lloyd, Clare
    Snelgrove, Robert
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [24] THE RELATIONSHIP BETWEEN FENO AND RESPONSE TO ANTI-IL5/5R BIOLOGIC THERAPIES IN SEVERE EOSINOPHILIC ASTHMA
    Hearn, A. P.
    Kavanagh, J.
    d'Ancona, G.
    Fernandes, M.
    Green, L.
    Roxas, C.
    Thomson, L.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2021, 76 : A143 - A144
  • [25] Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
    Burkill, S.
    Porsbjerg, C. M.
    Bourdin, A.
    Tran, T. N.
    Martin, N.
    Katial, R.
    Barker, P.
    Wechsler, M. E.
    Maspero, J.
    Bosnic-Anticevich, S.
    Chung, L. P.
    Katsoulotos, G.
    Christoff, G. C.
    Popov, T. A.
    Sadatsafavi, M.
    Torres-Duque, C. A.
    Ulrik, C.
    Assing, K. Dahl
    Hansen, S.
    Altraja, A.
    Lehtimaki, L. A.
    Papadopoulos, N. G.
    Kostikas, K.
    Salvi, S.
    Costello, R. W.
    Francesca, P.
    Iwanaga, T.
    Rhee, C. K.
    Al-Ahmad, M.
    Larenas-Linnemann, D.
    Fonseca, J. A.
    Amaral, R.
    Alving, K.
    Al-Lehebi, R.
    De-Llano, L. Perez
    Kirenga, B.
    Tsai, M.
    Mahboub, B.
    Pfeffer, P. E.
    Henley, W.
    Liu, Y.
    Lyu, J.
    Goh, C.
    Uthaman, T.
    Price, D.
    Townend, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [26] Anti-IL5 /Rituximab Therapy for Patients suffering from therapy-refractory Eosinophilic Granulomatosis with Polyangiitis
    Gysan, Maximilian Robert
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 601 - 601
  • [27] Anti-IL5/IL5R Treatment in COPD: Should We Target Oral Corticosteroid-Dependent Patients?
    Laroche, Jeremy
    Pelletier, Genevieve
    Boulay, Marie-Eve
    Cote, Andreanne
    Godbout, Krystelle
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 755 - 763
  • [28] The impact of anti-IL5 therapies in allergic patients with severe asthma, with and without fungal sensitization
    Colque-Bayona, M.
    Concha Llona, I. Fernandez
    Laorden Escudero, D.
    Losantos Garcia, I.
    Navarro-Cascales, T.
    Dominguez-Ortega, J.
    ALLERGY, 2023, 78
  • [29] Combination anti-IgE and anti-IL5 therapies in patients with severe persistent asthma and allergic bronchopulmonary aspergillosis (ABPA)
    Patel, Jay
    Ayars, Andrew G.
    Rampur, Lahari
    Bronson, Stephen
    Altman, Matthew C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB234 - AB234
  • [30] Differential PTGDR2 Expression In Blood Cell Populations From Asthmatic Patients After Treatment With Anti-IL5 Or Anti-IL4R
    Martin, Maria
    Estravis, Miguel
    Garcia-Sanchez, Asuncion
    Perez-Pazos, Jaqueline
    Martin-Garcia, Cristina
    Davila, Ignacio
    Sanz, Catalina
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB326 - AB326
12345